Page last updated: 2024-08-25

tetrandrine and Cardiomegaly

tetrandrine has been researched along with Cardiomegaly in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Jie, QQ; Jin, YG; Li, G; Li, WR; Wang, CY; Wu, L1
Bian, ZY; Li, H; Liu, C; Shen, DF; Tang, QZ; Wang, L; Yan, L; Zhang, Y; Zhu, LH1

Other Studies

2 other study(ies) available for tetrandrine and Cardiomegaly

ArticleYear
Tetrandrine Attenuated Doxorubicin-Induced Acute Cardiac Injury in Mice.
    BioMed research international, 2020, Volume: 2020

    Topics: Animals; Apoptosis; Benzylisoquinolines; Cardiomegaly; Cardiotoxicity; Cell Survival; Doxorubicin; Heart Injuries; Male; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; Signal Transduction

2020
Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling.
    British journal of pharmacology, 2010, Volume: 159, Issue:4

    Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Benzylisoquinolines; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Disease Models, Animal; Enzyme Activation; Fibrosis; Heart Failure; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; NF-kappa B; NFATC Transcription Factors; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Recovery of Function; Signal Transduction; Time Factors; Transfection; Ultrasonography; Ventricular Function, Left

2010